Outwitting evolution: fighting drug-resistant TB, malaria, and HIV.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22424234.
- Also identified by DOI 10.1016/j.cell.2012.02.021 and PMC identifier 3322542.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although caused by vastly different pathogens, the world's three most serious infectious diseases, tuberculosis, malaria, and HIV-1 infection, share the common problem of drug resistance. The pace of drug development has been very slow for tuberculosis and malaria and rapid for HIV-1. But for each disease, resistance to most drugs has appeared quickly after the introduction of the drug. Learning how to manage and prevent resistance is a major medical challenge that requires an understanding of the evolutionary dynamics of each pathogen. This Review summarizes the similarities and differences in the evolution of drug resistance for these three pathogens.
Medical subject headings
- Drug Resistance
- HIV Infections
- Malaria
- Tuberculosis